Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

PHCY523 Applied Clinical Pharmacy 2

Medication in the treatment of diseases including mental health, neurological disorders, women’s health, dermatology, infection, and therapeutic drug monitoring and pharmacokinetics.

Want to be able to confidently recommend and discuss evidence-based pharmacotherapy for your patients? The vast array of medications available to treat diseases makes it very important that pharmacists have the depth of understanding of pharmacotherapy in order to serve as knowledge navigators for patients and other health professionals. The unique depth of knowledge enables pharmacists to optimise medicines therapy and reduce drug-related morbidity and mortality. This paper helps pharmacists become active members of the health care team, contributing to optimising medicines-related health outcomes and being recognised as having specialised knowledge.

Paper title Applied Clinical Pharmacy 2
Paper code PHCY523
Subject Pharmacy
EFTS 0.2500
Points 30 points
Teaching period Second Semester (1 July 2017 - 11 November 2017)
Domestic Tuition Fees (NZD) $2,692.75
International Tuition Fees (NZD) $9,125.00

^ Top of page

Restriction
PHCX 525, PHCY 525, PHCX 523
Limited to
MHealSc, PGDipClinPharm, PGDipHealSc
Eligibility
This paper is targeted at pharmacists who wish to spend the majority of their time providing clinical pharmacy services and applying the skills gained to the optimal care of patients as part of a high-functioning health care team.
Contact
bruce.russell@otago.ac.nz
Teaching staff
Paper Co-ordinator: Associate Professor Bruce Russell
Professional Practice Fellow: Mr Keith Crump
Paper Structure
This paper involves studying specific disease areas and the use of evidence-based pharmacotherapy in the treatment of diseases and preparation of patient-centric care plans for actual patients, which includes information gathering, patient assessment, evaluation of all aspects of pharmacotherapy, care planning, communication of the plan, and follow up.
Teaching Arrangements
One compulsory 2-day weekend workshop in July and five 2-hour videoconferences.
Textbooks
No specific textbook requirements
Graduate Attributes Emphasised
Lifelong learning, Communication, Critical thinking, Self-motivation.
View more information about Otago's graduate attributes.
Learning Outcomes
Students who successfully complete the paper will be able to
  • Describe the pathophysiologic basis of the diseases and disorders covered
  • Discuss, in depth, the pharmacological basis of current therapeutics
  • Highlight and evaluate areas of therapeutic controversy and new drug developments
  • Fluently and confidently use clinical terminology
  • Quantify likely adverse effects and interactions in terms of the relevance to an individual
  • Apply pharmacotherapy knowledge and problem-solving skills to improve the medication management for specific patients, including accounting for all factors influencing the person's medicines use
  • Communicate clear and concise therapeutic information in oral and written form

^ Top of page

Timetable

Second Semester (1 July 2017 - 11 November 2017)

Location
Dunedin
Teaching method
This paper is taught through Distance Learning
Learning management system
Blackboard

Medication in the treatment of diseases including mental health, neurological disorders, women’s health, dermatology, infection, the management of pain and pharmacokinetics.

Want to be able to confidently recommend and discuss evidence-based pharmacotherapy for your patients? The vast array of medications available to treat diseases makes it very important that pharmacists have the depth of understanding of pharmacotherapy in order to serve as knowledge navigators for patients and other health professionals. The unique depth of knowledge enables pharmacists to optimise medicines therapy and reduce drug-related morbidity and mortality. This paper helps pharmacists become active members of the health care team, contributing to optimising medicines-related health outcomes and being recognised as having specialised knowledge.

Paper title Applied Clinical Pharmacy 2
Paper code PHCY523
Subject Pharmacy
EFTS 0.2500
Points 30 points
Teaching period Second Semester (1 July 2018 - 10 November 2018)
Domestic Tuition Fees Tuition Fees for 2018 have not yet been set
International Tuition Fees Tuition Fees for international students are elsewhere on this website.

^ Top of page

Restriction
PHCX 525, PHCY 525, PHCX 523
Limited to
MHealSc, PGDipClinPharm, PGDipHealSc
Eligibility
This paper is targeted at pharmacists who wish to spend the majority of their time providing clinical pharmacy services and applying the skills gained to the optimal care of patients as part of a high-functioning health care team.
Contact
bruce.russell@otago.ac.nz
Teaching staff
Paper Co-ordinator: Associate Professor Bruce Russell
Professional Practice Fellow: Mr Keith Crump
Paper Structure
This paper involves studying specific disease areas and the use of evidence-based pharmacotherapy in the treatment of diseases and preparation of patient-centric care plans for actual patients, which includes information gathering, patient assessment, evaluation of all aspects of pharmacotherapy, care planning, communication of the plan, and follow up.
Teaching Arrangements
One compulsory 2-day weekend workshop in July and five 2-hour videoconferences.
Textbooks
No specific textbook requirements
Graduate Attributes Emphasised
Lifelong learning, Communication, Critical thinking, Self-motivation.
View more information about Otago's graduate attributes.
Learning Outcomes
Students who successfully complete the paper will be able to
  • Describe the pathophysiologic basis of the diseases and disorders covered
  • Discuss, in depth, the pharmacological basis of current therapeutics
  • Highlight and evaluate areas of therapeutic controversy and new drug developments
  • Fluently and confidently use clinical terminology
  • Quantify likely adverse effects and interactions in terms of the relevance to an individual
  • Apply pharmacotherapy knowledge and problem-solving skills to improve the medication management for specific patients, including accounting for all factors influencing the person's medicines use
  • Communicate clear and concise therapeutic information in oral and written form

^ Top of page

Timetable

Second Semester (1 July 2018 - 10 November 2018)

Location
Dunedin
Teaching method
This paper is taught through Distance Learning
Learning management system
Blackboard